FDA accepts marketing application of Amarin's heart pill
by on Nov.25, 2011, under Health and Fitness
Biopharmaceutical company Amarin Corp said U.S. health regulators have accepted the marketing application for its heart pill AMR101 and set an eight-month review period.
View full post on Yahoo! Health News
